Search
Search Results
##search.searchResults.foundPlural##
-
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4670PDF: 1326HTML: 1917Untitled: 182Untitled: 177 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1388HTML: 469PDF: 827 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1361PDF: 839HTML: 137 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1974PDF: 756HTML: 698 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3563PDF: 2429HTML: 1475 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
726PDF: 466HTML: 6270 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2853PDF: 852HTML: 6528Untitled: 228Untitled: 193Untitled: 206Untitled: 217 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1302PDF: 942HTML: 91 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3594PDF: 1642HTML: 2677 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1600PDF: 511HTML: 164 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2592PDF: 804HTML: 5220 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1632PDF: 802HTML: 862jdoe, table 2 infections CML .doc: 195jdoe, table 1 infections CML .doc: 181 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1547PDF: 957HTML: 229 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13265PDF: 973HTML: 7293 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6861PDF: 3653HTML: 753 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2036PDF: 805HTML: 1046 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3288PDF: 1248HTML: 8111 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2192PDF: 1201HTML: 3748 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1546PDF: 782HTML: 204 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4786PDF: 2846HTML: 2294 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1293PDF: 607HTML: 3101 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1738PDF: 778HTML: 524 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4333PDF: 1492HTML: 1552Untitled: 232 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2357PDF: 938HTML: 309 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1234PDF: 593HTML: 2865ATRA induced Reactive Hemophagocytosis: A Case Report: 199 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1792PDF: 976HTML: 146







